Advertisement
Business
Why Eli Lilly Is Buying Centessa for $7.8 Billion
March 31, 2026
Bloomberg
Scroll
Bloomberg Intelligence's Sam Fazeli discusses Eli Lilly's 7.8 billion acquisition of Centessa, marking the company's entry into the sleep disorder drug market. He speaks on Bloomberg Open Interest. (Source: Bloomberg)
Bloomberg
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
Advertisement